Skip to main content
. 2004 Oct 25;4(Suppl 10):105–109. doi: 10.1111/j.1600-6135.2004.00734.x

Table 1.

Overview of the diagnosis and treatment of common community acquired respiratory viral infections in solid organ transplant recipients

Virus Diagnostic test (s) Treatment (s)
Respiratory syncytial virus Antigen detection Upper respiratory tract & no risk factors:
Nucleic acid detection  Supportive care
Viral culture Upper respiratory tract & risk factors or
Shell vial culture Lower respiratory tract:
 Aerosolized ribavirin in combination with RSV IVIG or pavilizumab should be considered (BIII)
Influenza Viral culture Influenza A infection:
Shell vial culture  amantadine, rimantadine, zanamivi
Antigen detection  and oseltamivir (BIII)
Influenza B infection: 
 zanamivir and oseltamivir (BIII)
Consider addition of aerosolized ribavirin for severe lower respiratory tract disease (CIII)
Parainfluenza Viral culture Upper respiratory tract infection:
Shell vial culture Supportive care
Antigen detection Lower respiratory tract infection:
Nucleic acid detection Supportive care
Consider aerosolized ribavirin (CIII) as no other options but experience to date provides little evidence for likely efficacy